Mathieu Robain
Impact in
- Virology top 10%
- HIV Research and Treatment
-
- Hepatitis C virus research
Papers in
- Oncology 18
- Cancer Treatment and Pharmacology 12
-
- Advanced Breast Cancer Therapies 9
- Co-authors
- Laurence Meyer (5 shared papers)Jean‐Yves Pierga (4 shared papers)Bernard Asselain (5 shared papers)Élisabeth Dussaix (4 shared papers)Nicolas Carré (3 shared papers)Dominique Salmon‐Céron (3 shared papers)Denise Stevens (1 shared paper)Roman Rouzier (2 shared papers)
In The Last Decade
Mathieu Robain
31 papers receiving 261 citations
Peers
Comparison fields: 5 of 61
- Virology 43
- Hepatology 36
- Oncology 106
- Cancer Research 55
- Genetics 26
Countries citing papers authored by Mathieu Robain
This map shows the geographic impact of Mathieu Robain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Robain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Robain more than expected).
Fields of papers citing papers by Mathieu Robain
This network shows the impact of papers produced by Mathieu Robain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Robain. The network helps show where Mathieu Robain may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathieu Robain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 44 | |
| 2 | 2001 | 29 | |
| 3 | 2001 | 25 | |
| 4 | 2002 | 23 | |
| 5 | 1998 | 22 | |
| 6 | 2001 | 19 | |
| 7 | 2000 | 16 | |
| 8 | 2005 | 14 | |
| 9 | 2017 | 6 | |
| 10 | 1997 | 6 | |
| 11 | [Invasive group A streptococcal infections in France]. | 1995 | 6 |
| 12 | 2017 | 5 | |
| 13 | 2023 | 5 | |
| 14 | 2000 | 5 | |
| 15 | 2021 | 5 | |
| 16 | 2016 | 4 | |
| 17 | 2022 | 3 | |
| 18 | 2020 | 3 | |
| 19 | 2015 | 3 | |
| 20 | 2024 | 3 |
About Mathieu Robain
Mathieu Robain is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Economics and Econometrics and Cancer Research, having authored 33 papers that have together received 266 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (12 papers), Advanced Breast Cancer Therapies (9 papers), Breast Cancer Treatment Studies (5 papers), Cytomegalovirus and herpesvirus research (5 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), HIV Research and Treatment (4 papers), Healthcare Systems and Practices (4 papers) and Hepatitis B Virus Studies (3 papers). The work is most often cited by research in Virology (43 citations), Hepatology (36 citations), Oncology (106 citations), Cancer Research (55 citations) and Genetics (26 citations). Mathieu Robain has collaborated with scholars based in France, Canada and Germany. Frequent co-authors include Laurence Meyer, Jean‐Yves Pierga, Bernard Asselain, Élisabeth Dussaix, Nicolas Carré, Dominique Salmon‐Céron, Denise Stevens, Roman Rouzier, Florence Lerebours and Fabien Reyal. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, PLoS ONE and Sexually Transmitted Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.